In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 3, 2013, Pages 226-235

  Kuznetsov, Sergei A ^a   Mankani, Mahesh H ^a,b   Robey, Pamela Gehron ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ascorbic acid phosphate; Bone formation; Dexamethasone; Haematopoietic territories; Human bone marrow stromal cells; In vitro cultivation; In vivo transplantation

Indexed keywords

BONE; CELL CULTURE; CELLS; TISSUE ENGINEERING;

ASCORBIC ACID PHOSPHATE; BONE FORMATION; DEXAMETHASONES; HEMATOPOIETIC TERRITORY; HUMAN BONE MARROW STROMAL CELLS; IN VITRO CULTIVATION; IN VIVO TRANSPLANTATION; IN-VITRO; IN-VIVO; VITRO CULTIVATION;

ASCORBIC ACID;

ASCORBIC ACID; ASCORBIC ACID PHOSPHATE; DEXAMETHASONE; PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL PROLIFERATION; CELL SUSPENSION; CHILD; COLONY FORMING UNIT; EX VIVO STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VIVO STUDY; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STROMA CELL;

EID: 84874699768     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.515     Document Type: Article

References (64)

1. Bennett JH, Joyner CJ, Triffit JT, et al. 1991; Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 99(1): 131-139.
2. Beresford JN, Joyner CJ, Devlin C, et al. 1994; The effects of dexamethasone and 1, 25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39: 941-947.
3. Bianco P, Robey PG. 2004; Skeletal stem cells. In Handbook of Adult and Fetal Stem Cells, Lanza RP (ed). Academic Press: San Diego, CA.
4. Bruder SP, Kurth AA, Shea M, et al. 1998; Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16: 155-162.
5. Canalis E. 1983; Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112: 931-939.
6. Castano-Izquierdo H, Alvarez-Barreto J, Van den Dolder J, et al. 2007; Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A 82: 129-138.
7. Chailakhian RK, Gerasimov IUV, Fridenshtein A. 1978; Bone marrow microenvironment transfer by clones of stromal mechanocytes. Biull Eksp Biol Med 86: 705-707.
8. Chen J, Sotome S, Wang J, et al. 2005; Correlation of in vivo bone formation capability and in vitro differentiation of human bone marrow stromal cells. J Med Dent Sci 52: 27-34.
9. Chen TL, Feldman D. 1979; Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production. J Clin Invest 63: 750-758.
10. Cheng SL, Yang JW, Rifas L, et al. 1994; Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134: 277-286.
11. Cheng SL, Zhang SF, Avioli LV. 1996; Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells. J Cell Biochem 61: 182-193.
12. Choi KM, Seo YK, Yoon HH, et al. 2008; Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng 105: 586-594.
13. Cicconetti A, Sacchetti B, Bartola A, et al. 2007; Human maxillary tuberosity and jaw periosteum as sources of osteoprogenitor cells for tissue engineering. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: 618.e1-e12.
14. Derubeis AR, Mastrogiacomo M, Cancedda R, et al. 2003; Osteogenic potential of rat spleen stromal cells. Eur J Cell Biol 82: 175-181.
15. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. 1987; Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20: 263-272.
16. Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. 1974; Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340.
17. Freidenstein AJ, Latzinik NW, Grosheva AG, et al. 1982; Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 10: 217-227.
18. Fromigue O, Marie PJ, Lomri A. 1997; Differential effects of transforming growth factor β2, dexamethasone and 1, 25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9: 613-623.
19. Garg A, Wilson R, Barnes R, et al. 1999; A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J .Clin Endocrinol Metab 84: 3390-3394.
20. Gerasimov IuV, Fridenshtein A, Chailakhian RK, et al. 1986; Differentiation potentials of clonal strains of bone marrow fibroblasts. Biull Eksp Biol Med 101: 717-719.
21. Hata R, Senoo H. 1989; l-Ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissue-like substance by skin fibroblasts. J Cell Physiol 138: 8-16.
22. Hegele RA. 2000; Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome. Mol Genet Metab 71: 539-544.
23. Herbertson A, Aubin JE. 1995; Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 10: 285-294.
24. Jaquiery C, Schaeren S, Farhadi J, et al. 2005; In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Ann Surg 242: 859-867; discussion, 867-868.
25. Jeffrey JJ, Martin GR. 1966; The role of ascorbic acid in the biosynthesis of collagen. I. Ascorbic acid requirement by embryonic chick tibia in tissue culture. Biochim Biophys Acta 121: 269-280.
26. Juneja HS, Minguell JJ, Gardner FH, et al. 1984; The effect of dexamethasone on the growth of bone marrow fibroblasts in aplastic anemia. Prog Clin Biol Res 154: 265-274.
27. Kasugai S, Todescan R Jr, Nagata T, et al. 1991; Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol 147: 111-120.
28. Kim CH, Cheng SL, Kim GS. 1999; Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss. J Endocrinol 162: 371-379.
29. Kitoh H, Kitakoji T, Tsuchiyah H, et al. 2007; Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 40: 522-528.
30. Koh Y, Lee HR, Song EY, et al. 2010; Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA). Leuk Res 34: 1344-1350.
31. Krebsbach PH, Kuznetsov SA, Satomura K, et al. 1997; Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 1059-1069.
32. Krebsbach PH, Mankani MH, Satomura K, et al. 1998; Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66: 1272-1278.
33. Krzymanski G, Wiktor-Jedrzejczak W. 1996; Autologous bone marrow-derived stromal fibroblastoid cells grown in vitro for the treatment of defects of mandibular bones. Transpl Proc 28: 3528-3530.
34. Kuznetsov S, Gehron Robey P. 1996; Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int 59: 265-270.
35. Kuznetsov SA, Cherman N, Robey PG. 2011; In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev 20: 269-287.
36. Kuznetsov SA, Friedenstein AJ, Robey PG. 1997a; Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 97: 561-570.
37. Kuznetsov SA, Huang KE, Marshall GW, et al. 2008; Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/tricalcium phosphate. Biomaterials 29: 4211-4216.
38. Kuznetsov SA, Krebsbach PH, Satomura K, et al. 1997b; Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12: 1335-1347.
39. Kuznetsov SA, Mankani MH, Bianco P, et al. 2009; Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res 2: 83-94.
40. Kuznetsov SA, Mankani MH, Robey PG. 2000; Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70: 1780-1787.
41. Mankani MH, Kuznetsov SA, Fowler B, et al. 2001; In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72: 96-107.
42. Mankani MH, Kuznetsov SA, Robey PG. 2007; Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. Exp Hematol 35: 995-1004.
43. Mankani MH, Kuznetsov SA, Shannon B, et al. 2006a; Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol 168: 542-550.
44. Mankani MH, Kuznetsov SA, Wolfe RM, et al. 2006b; In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells 24: 2140-2149.
45. Marcacci M, Kon E, Moukhachev V, et al. 2007; Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13: 947-955.
46. Mendes SC, Tibbe JM, Veenhof M, et al. 2004; Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 15: 1123-1128.
47. Muraglia A, Cancedda R, Quarto R. 2000; Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113(7): 1161-1166.
48. Osepjan IA, Chailakhjan RK, Garibjan ES, et al. 1987; Treatment of non-unions, pseudoarthroses, and long bone defects by transplantation of autologous bone marrow fibroblasts grown in vitro and embedded into a spongeous bone matrix. Orthop Traumatol 9: 59-61.
49. Owen M. 1988; Marrow stromal stem cells. J Cell Sci Suppl 10: 63-76.
50. Owen M, Friedenstein AJ. 1988; Stromal stem cells: marrow-derived osteogenic precursors. CIBA Found Symp 136: 42-60.
51. Peck WA, Messinger K, Brandt J, et al. 1969; Impaired accumulation of ribonucleic acid precursors and depletion of ribonucleic acid in glucocorticoid-treated bone cells. J Biol Chem 244: 4174-4184.
52. Pinnell SR. 1985; Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J Biol Med 58: 553-559.
53. Pri-Chen S, Pitaru S, Lokiec F, et al. 1998; Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23: 111-117.
54. Quarto R, Mastrogiacomo M, Cancedda R, et al. 2001; Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344: 385-386.
55. Sabatini F, Petecchia L, Tavian M, et al. 2005; Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 85: 962-971.
56. Sabharwal S. 2009; Blount disease. J Bone Joint Surg Am 91: 1758-1776.
57. Sacchetti B, Funari A, Michienzi S, et al. 2007; Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
58. Song IH, Caplan AI, Dennis JE. 2009; In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res 27: 916-921.
59. Sudo K, Kanno M, Miharada K, et al. 2007; Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells 25: 1610-1617.
60. Tsirikos AI, Garrido EG. 2010; Spondylolysis and spondylolisthesis in children and adolescents. J Bone Joint Surg Br 92: 751-759.
61. Ueda M, Yamada Y, Ozawar R, et al. 2005; Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement. Int J Periodont Restor Dent 25: 129-37.
62. Weinstein RS, Jilka RL, Parfitt AM, et al. 1998; Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282.
63. Xiao Y, Peperak V, Van Rijn L, et al. 2010; Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells. J Tissue Eng Regen Med 4: 374-386.
64. Yamanouchi K, Satomura K, Gotoh Y, et al. 2001; Bone formation by transplanted human osteoblasts cultured within collagen sponge with dexamethasone in vitro. J Bone Miner Res 16: 857-867.